Botanical species · safety record

Anagyris foetida

The EFSA Compendium of Botanicals holds 9 constituent measurements and 1 adverse-effect record for Anagyris foetida. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anagyris foetida L.

9Constituent measurements

1Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Anagyrine	Leaves	Solvent extraction	—	HPLC-DAD	Resolve DOI
Baptifoline	Leaves	Solvent extraction	—	HPLC-DAD	Resolve DOI
(-)-sparteine	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Alkaloids	Stem / stalk	Drying (dehydration)	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Cytisine	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Lupanine	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
N-methylcytisine	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Quinolizidine alkaloids	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Scopoletin	Unspecified	—	—	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Neurologic: central nervous system	Live plants	—	Human (as organism)	Case report	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Al-Azizi, M. M., Al-Said, M. S., El-Olemy, M. M., Sattar, E. Abdel., Khalifa, A. S. Rhombifoline and 5,6-dehydrolupanine from Anagyrus foetida L.. Archives of pharmacal research, 1994, vol. 17, no. 6, p. 393-7.
El-Beih, F. K. A. Constituents of local plants. XVII. The coumarin constituents of Anagyris foetida L. Herba hungarica, 1984, vol. 23(1-2), p. 127-30.
Al-Qura'n, S. Ethnobotanical survey of folk toxic plants in southern part of Jordan. Toxicon, 2005, vol. 46, no. 2, p. 119-129. DOI
Innocenti, G., Dall'Acqua, S., Viola, G., Loi, M. C. Cytotoxic constituents from Anagyris foetida leaves. Fitoterapia, 2006, vol. 77, no. 7-8, p. 595-597. DOI
Adzet, T., Batllori, L., San Martin, R. Alkaloids of some Genisteae species of Catalonia (Spain). Plantes medicinales et phytotherapie, 1970, vol. 4, no. 1, p. 21-3.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature